Lataa...
Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer
Implementation of the Oncotype DX assay has led to a change in the manner in which chemotherapy is utilized in patients with early stage, estrogen receptor (ER)-positive, node-negative breast cancer; ensuring that patients at highest risk of recurrence are prescribed systemic treatment, while at the...
Tallennettuna:
| Julkaisussa: | Breast Cancer (Dove Med Press) |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5459968/ https://ncbi.nlm.nih.gov/pubmed/28615971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S109847 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|